87914539 - GEOMX

Information

• Trademark
• 87914539

• Source

• Serial Number

  87914539

• International Classifications

  • 5 - Pharmaceutical and veterinary preparations

• Filing Date

  May 09, 2018
  6 years ago

• Transaction Date

  December 13, 2024
  2 months ago

• Status Date

  June 16, 2022
  2 years ago

• Published for Opposition Date

  December 11, 2018
  6 years ago

• Location Date

  June 16, 2022
  2 years ago

• First Use Anywhere Date

  September 05, 2018
  6 years ago

• First Use In Commerce Date

  September 05, 2018
  6 years ago

• Status Code

  602

• Current Location

  TMO LAW OFFICE 130 - EXAMINING ATTORNEY ASSIGNED

  Employee Name

  RATCLIFFE, ROBERT

• Attorney Docket Number

  31353-TM1042

  Attorney Name

  Alyssa Worsham

  Law Office Assigned Location Code

  O30

• Owners

  • NANOSTRING TECHNOLOGIES, INC

Case File Statements

• GS0051: diagnostic reagents and instruments for medical or veterinary use in the fields of pathology, immunohistochemistry, in situ-hybridization, proteomics, RNA transcription, RNA translation, gene expression profiling and nucleic acid sequencing; diagnostic reagents for medical or veterinary use in the fields of cancer, neurology and infectious disease; diagnostic reagent kits comprising primarily of diagnostic reagents for medical or veterinary use in the fields of cancer, neurology and infectious disease; chemical reagents for medical use; reagents for medical or veterinary use containing antibodies and nucleic acids; diagnostic test kits for medical use comprising primarily reagents, slides, solid matrix materials, microfluidic devices sold as a unit with instructional manuals therefor; medical or veterinary diagnostic kits comprising medical or veterinary diagnostic reagents for use in detecting the presence of analytes in samples and identifying sample type, and equipment, namely, medical diagnostic immuno-assays for screening samples detecting the presence of analytes in samples and identifying sample type, sold as a unit with instructional manuals; diagnostic preparations in the nature of antibodies, for medical and veterinary purposes; reagents and diagnostic reagents for medical or veterinary purposes; diagnostic preparations in the nature of in situ hybridization probes, for medical and veterinary purposes; medical or veterinary diagnostic reagents for pathology, immunohistochemistry, in situ-hybridization, proteomics, RNA transcription, RNA translation, gene expression profiling and nucleic acid sequencing; multiparameter quantitative detection and analysis products and technology for diagnostics for a variety of uses in health care, namely, pathology, immunohistochemistry, in situ-hybridization, proteomics, RNA transcription, RNA translation, gene expression profiling and nucleic acid sequencing; medical diagnostic reagents and assays for testing of body fluids or tissue; kits consisting primarily of medical or veterinary diagnostic reagents and assays for testing of body fluids or tissue; reagents in the form of cell markers and molecule markers including antibodies and nucleic acids for medical or veterinary purposes; medical diagnostic reagents for use in the fields of pathology, immunohistochemistry, in situ-hybridization, proteomics, RNA transcription, RNA translation, gene expression profiling and nucleic acid sequencing; medical diagnostic reagents for use relating to molecular identification and digital quantification; medical diagnostic reagents containing antibodies and nucleic acids; medical diagnostic reagents for use in the fields of cancer, neurology and infectious disease; medical diagnostic reagents for immuno-histochemistry detection and in situ-hybridization detection; medical diagnostic reagents for use relating to molecular identification and digital quantification

Case File Event Statements

• 8/31/2018 - 6 years ago

  4 - PRIORITY ACTION WRITTEN Type: CPRA

• 5/12/2018 - 6 years ago

  1 - NEW APPLICATION ENTERED Type: NWAP

• 5/18/2018 - 6 years ago

  2 - NEW APPLICATION OFFICE SUPPLIED DATA ENTERED Type: NWOS

• 8/30/2018 - 6 years ago

  3 - ASSIGNED TO EXAMINER Type: DOCK

• 8/31/2018 - 6 years ago

  5 - PRIORITY ACTION E-MAILED Type: GPRA

• 8/31/2018 - 6 years ago

  6 - NOTIFICATION OF PRIORITY ACTION E-MAILED Type: GPRN

• 10/14/2018 - 6 years ago

  7 - TEAS RESPONSE TO OFFICE ACTION RECEIVED Type: TROA

• 10/14/2018 - 6 years ago

  8 - CORRESPONDENCE RECEIVED IN LAW OFFICE Type: CRFA

• 10/15/2018 - 6 years ago

  9 - TEAS/EMAIL CORRESPONDENCE ENTERED Type: TEME

• 10/18/2018 - 6 years ago

  10 - APPROVED FOR PUB - PRINCIPAL REGISTER Type: CNSA

• 11/2/2018 - 6 years ago

  11 - ASSIGNED TO LIE Type: ALIE

• 11/2/2018 - 6 years ago

  12 - LAW OFFICE PUBLICATION REVIEW COMPLETED Type: PREV

• 11/21/2018 - 6 years ago

  13 - NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED Type: NONP

• 12/11/2018 - 6 years ago

  14 - PUBLISHED FOR OPPOSITION Type: PUBO

• 12/11/2018 - 6 years ago

  15 - OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED Type: NPUB

• 2/5/2019 - 6 years ago

  16 - NOA E-MAILED - SOU REQUIRED FROM APPLICANT Type: NOAM

• 8/5/2019 - 5 years ago

  22 - SOU EXTENSION 1 FILED Type: EXT1

• 8/15/2019 - 5 years ago

  17 - TEAS PETITION TO REVIVE RECEIVED Type: PROA

• 8/15/2019 - 5 years ago

  18 - PETITION TO REVIVE-GRANTED Type: PETG

• 8/15/2019 - 5 years ago

  19 - SOU EXTENSION RECEIVED WITH TEAS PETITION Type: TPEX

• 8/15/2019 - 5 years ago

  20 - NOTICE OF REVIVAL - E-MAILED Type: NREV

• 10/2/2019 - 5 years ago

  21 - CASE ASSIGNED TO INTENT TO USE PARALEGAL Type: AITU

• 10/2/2019 - 5 years ago

  23 - SOU EXTENSION 1 GRANTED Type: EX1G

• 10/3/2019 - 5 years ago

  24 - NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED Type: EXRA

• 10/23/2019 - 5 years ago

  25 - TEAS REQUEST TO DIVIDE RECEIVED Type: ERTD

• 10/23/2019 - 5 years ago

  27 - DIVISIONAL REQUEST RECEIVED Type: DRRR

• 10/25/2019 - 5 years ago

  26 - CASE ASSIGNED TO INTENT TO USE PARALEGAL Type: AITU

• 10/28/2019 - 5 years ago

  28 - DIVISIONAL PROCESSING COMPLETE Type: DPCC

• 10/29/2019 - 5 years ago

  29 - CORRECTED NOA E-MAILED Type: NOAC

• 1/30/2020 - 5 years ago

  30 - SOU TEAS EXTENSION RECEIVED Type: EEXT

• 1/30/2020 - 5 years ago

  31 - SOU EXTENSION 2 FILED Type: EXT2

• 1/30/2020 - 5 years ago

  32 - SOU EXTENSION 2 GRANTED Type: EX2G

• 2/1/2020 - 5 years ago

  33 - NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED Type: EXRA

• 7/20/2020 - 4 years ago

  34 - SOU TEAS EXTENSION RECEIVED Type: EEXT

• 7/20/2020 - 4 years ago

  35 - SOU EXTENSION 3 FILED Type: EXT3

• 7/20/2020 - 4 years ago

  36 - SOU EXTENSION 3 GRANTED Type: EX3G

• 1/20/2021 - 4 years ago

  39 - SOU EXTENSION 4 FILED Type: EXT4

• 7/22/2020 - 4 years ago

  37 - NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED Type: EXRA

• 1/20/2021 - 4 years ago

  38 - SOU TEAS EXTENSION RECEIVED Type: EEXT

• 1/20/2021 - 4 years ago

  40 - SOU EXTENSION 4 GRANTED Type: EX4G

• 8/16/2021 - 3 years ago

  45 - SOU EXTENSION 5 GRANTED Type: EX5G

• 1/22/2021 - 4 years ago

  41 - NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED Type: EXRA

• 8/5/2021 - 3 years ago

  42 - TEAS STATEMENT OF USE RECEIVED Type: EISU

• 8/5/2021 - 3 years ago

  43 - SOU TEAS EXTENSION RECEIVED Type: EEXT

• 8/5/2021 - 3 years ago

  44 - SOU EXTENSION 5 FILED Type: EXT5

• 8/5/2021 - 3 years ago

  46 - USE AMENDMENT FILED Type: IUAF

• 8/16/2021 - 3 years ago

  47 - STATEMENT OF USE PROCESSING COMPLETE Type: SUPC

• 8/19/2021 - 3 years ago

  49 - ASSIGNED TO EXAMINER Type: DOCK

• 8/17/2021 - 3 years ago

  48 - NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED Type: EXRA

• 8/30/2021 - 3 years ago

  50 - ASSIGNED TO EXAMINER Type: DOCK

• 6/16/2022 - 2 years ago

  55 - ABANDONMENT NOTICE E-MAILED - FAILURE TO RESPOND Type: MAB2

• 12/3/2021 - 3 years ago

  51 - SU - NON-FINAL ACTION - WRITTEN Type: CNRT

• 12/3/2021 - 3 years ago

  52 - NON-FINAL ACTION E-MAILED Type: GNRT

• 12/3/2021 - 3 years ago

  53 - NOTIFICATION OF NON-FINAL ACTION E-MAILED Type: GNRN

• 6/16/2022 - 2 years ago

  54 - ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSE Type: ABN2